Mayo Clinic Pharmacy Grand Rounds

Shocking Update: The Use of Fludrocortisone in Septic Shock

Hailey Thompson, PharmD shares SHOCKing updates on the use of corticosteroids in septic shock.

For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.

You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Bad Blood: Anemia Management Updates in the Setting of Chronic Kidney Disease

Mark Layden, PharmD, MBA shares the place in therapy for hypoxia-inducible factor prolyl hydroxylase inhibitors and other general approaches to anemia management in chronic kidney disease.

For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.

You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

A Rumble in the Fungal Jungle: Review of the New Antifungal Agents

Natalie T. Hagy, PharmD shares new antifungal agents in the pipeline, their novel mechanisms of action, and available formulations.

For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.

You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Lost in the ECMO Chamber: Pharmacokinetics in Critical Illness

Ming May Zhang, PharmD reviews pharmacokinetic considerations in extracorporeal membrane oxygenation.

For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.

You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Must be mAb on the Brain: A New Hope for Alzheimer’s Disease

Hailey Thompson, PharmD, reviews primary literature and shares updates on the role of monoclonal antibody therapies in the treatment of Alzheimer’s Disease.

For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.

You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

GPS for APS: Navigating Anticoagulation in Antiphospholipid Syndrome

Caitlin Schanz, PharmD discusses antiphospholipid syndrome, with a focus on data comparing direct oral anticoagulants versus warfarin as anticoagulation strategies in these patients.

For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.

You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Waving Goodbye to the X Waiver: Reassessing Medication Treatment for Opioid Use Disorder

Tanner Melton, PharmD reviews literature on buprenorphine and methadone in treating opioid use disorder.

For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.

You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Give it a Shot! Long-Acting Injectables in HIV Therapy

Christopher Cahoon, PharmD elucidates the literature pertaining to injectable cabotegravir and rilpivirine as HIV therapy options.

For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.

You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Taking the LEAD? Dual Pathway Inhibition Therapy for Lower Extremity Arterial Disease

Shienna Braga, PharmD examines the literature pertaining to dual pathway inhibition for lower extremity arterial disease.

For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.

You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

What’s Been ‘Flozin On: Updates in Outpatient Management of Chronic Kidney Disease

Lauren Stonerock, PharmD describes updates in outpatient management of chronic kidney disease.

For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.

You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.